Tenet Surpasses Earnings, Eyes Growth | Business and Finance News

Tenet Healthcare’s Q2 earnings crush expectations with $5.6B in net revenue and $1.3B in adjusted EBITDA—up 16% year-over-year—thanks to smarter focus on high-acuity care and cost control. USPI surgery centers soar with 9% EBITDA growth and a 10% jump in joint replacements, while hospitals surge 22% in EBITDA. Despite a 17% hit from health insurance exchanges—worst in Florida and Texas—Tenet counters with disciplined cost adjustments and a $7M stock buyback. They’ve raised full-year EBITDA guidance to $4.83B–$5.03B, fueled by strong H1 performance and a $300M acquisition plan for ambulatory centers. Resilient, strategic, and growing—Tenet’s playbook is working. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/e2815c46a12dbc52